Kits Eyecare Stock Today
| KITS Stock | CAD 9.19 0.34 3.84% |
Performance0 of 100
| Odds Of DistressLess than 20
|
Kits Eyecare is selling at 9.19 as of the 2nd of December 2024; that is 3.84 percent increase since the beginning of the trading day. The stock's open price was 8.85. Kits Eyecare has about a 20 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Kits Eyecare are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of December 2022 and ending today, the 2nd of December 2024. Click here to learn more.
Business Domain Consumer Discretionary Distribution & Retail | Category Consumer Cyclical | Classification Consumer Discretionary |
Kits Eyecare Ltd. operates a digital eyecare platform for eyes in the United States and Canada. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. KITS EYECARE operates under Specialty Retail classification in Canada and is traded on Toronto Stock Exchange. The company has 31.58 M outstanding shares of which 9.08 K shares are now shorted by private and institutional investors with about 0.12 days to cover all short positions. More on Kits Eyecare
Moving against Kits Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Kits Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Kits Eyecare's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Kits Eyecare or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Other Specialty Retail, Consumer Discretionary Distribution & Retail, Consumer Discretionary, Consumer Discretionary, Specialty Retail, Specialty Retail, Consumer Cyclical (View all Sectors) | ||||
Kits Eyecare's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Kits Eyecare's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsKits Eyecare can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Kits Eyecare's financial leverage. It provides some insight into what part of Kits Eyecare's total assets is financed by creditors.
| |||||
Kits Eyecare (KITS) is traded on Toronto Exchange in Canada and employs 143 people. Kits Eyecare is listed under Other Specialty Retail category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 290.19 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kits Eyecare's market, we take the total number of its shares issued and multiply it by Kits Eyecare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kits Eyecare operates under Specialty Retail sector and is part of Consumer Discretionary industry. The entity has 31.58 M outstanding shares of which 9.08 K shares are now shorted by private and institutional investors with about 0.12 days to cover all short positions.
Kits Eyecare has accumulated about 18.79 M in cash with 2.4 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Check Kits Eyecare Probability Of Bankruptcy
Ownership AllocationKits Eyecare maintains a total of 31.58 Million outstanding shares. Kits Eyecare secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.76 % of Kits Eyecare outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kits Ownership Details
Kits Eyecare Risk Profiles
Although Kits Eyecare's alpha and beta are two of the key measurements used to evaluate Kits Eyecare's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.64 | |||
| Standard Deviation | 2.44 | |||
| Variance | 5.97 | |||
| Risk Adjusted Performance | (0.07) |
Kits Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Kits Eyecare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Kits Eyecare Corporate Management
Elected by the shareholders, the Kits Eyecare's board of directors comprises two types of representatives: Kits Eyecare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kits. The board's role is to monitor Kits Eyecare's management team and ensure that shareholders' interests are well served. Kits Eyecare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kits Eyecare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Thompson | CoFounder COO | Profile | |
| Sabrina Liak | President, CoFounder | Profile | |
| Allen Zhu | Controller | Profile | |
| Robert Long | Chief Officer | Profile | |
| Stefan Harvalias | Chief Officer | Profile | |
| Roger Hardy | CEO CoFounder | Profile |
Other Information on Investing in Kits Stock
Kits Eyecare financial ratios help investors to determine whether Kits Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kits with respect to the benefits of owning Kits Eyecare security.